Abstract:Different ratios of ETV-A in ETV binary mixtures were quantified.The DSC thermo-gram was selected to establish the standard curve for quantify the content of ETV-A in binary mixtures.ETV-A content PLS calibration curves of PXRD and ATR-FTIR data were established to quantify the content of ETV-A.The optimal preprocessing method was established.Entecavir (ETV), a guanosine analogue, can be rapidly phosphorylated to the active intracellular triphosphate form that inhibits replication of the hepatitis B virus (HBV). This work aims to develop useful methods to quantify the content of ETV-A in ETV-H and ETV-A binary mixtures. The integral enthalpy value of the phase transformation in the DSC thermogram was selected to quantify the content of ETV-A in binary mixture. Different ranges (full spectrum and partial spectrum) of the PXRD and ATR-FTIR data versus ETV-A content were used to develop partial least squares (PLS) calibration curves with different pre-processing algorithms including multiplicative scatter correction (MSC), standard normal variate (SNV), wavelet transform (WT) or their combinations. The standard curve obtained for the DSC technique is Y=100.455+7.255X, R2=0.997, in the ETV-A contents range of 0–100% w/w% in binary mixtures. Limit of detection (LOD) of ETV-A was 0.909% and limit of quantitation (LOQ) is 2.755%. The best correction models for PXRD and ATR-FTIR techniques, in the ETV-A contents range of 0–100% w/w% in binary mixtures, were Y=0.346+0.999X, R2 = 0.999 in the 2θ range of 4-6° with 14-34° and Y=0.767+0.991X, R2 = 0.991 in the range of 3500-2500 cm-1 with 2000-400 cm-1 pretreated by MSC+WT, respectively. Limit of detection (LOD) of ETV-A was 1.394% and limit of quantitation (LOQ) was 4.224% for PXRD technique. LOD and LOQ for ATR-FTIR technique were 9.124% and 27.648%. The results show that DSC, PXRD and ATR-FTIR techniques are precise and accurate, and could be used for the measurement of ETV-A content in the binary mixtures.

Determination of Optical Isomer Impurity in Entecavir by Enantiospecific High Performance Liquid Chromatography

An Enantiospecific HPLC Method for the Determination of (S)-Enantiomer Impurities in (R)-Tolterodine Tartarate.

Simultaneous Determination of Related Substances in Entecavir Film-Coated Tablet by High Performance Liquid Chromatography.

Chiral Detection of Entecavir Stereoisomeric Impurities Through Coordination with R-besivance and Zn-II Using Mass Spectrometry

[Enantiomeric Separation and Impurity Determination of Valaciclovir Hydrochloride].

Quantitative analysis of binary mixtures of entecavir using solid-state analytical techniques with chemometric methods

Quantitation of polymorphic impurity in entecavir polymorphic mixtures using powder X-ray diffractometry and Raman spectroscopy.

Low-Content Quantitation in Entecavir Tablets Using 1064 Nm Raman Spectroscopy

Determination of Enantiomeric Impurity in Besifloxacin Hydrochloride by Chiral High-Performance Liquid Chromatography with Precolumn Derivatization.

Separation Of Terfenadine Enantiomers By High Performance Liquid Chromatography Using Beta-Cyclodextrin As Chiral Mobile Phase Additive

Simultaneous Determination of Diastereoisomeric and Enantiomeric Impurities in (1r, 3R)-1-(1,3-benzodioxol-5-yl)-2-(chloroacetyl)-2,3,4,9-tetrahydro-1h-pyri Do[3,4-B]Indole-3-Carboxylic Acid Methyl Ester A Key Intermediate of Tadalafil by Chiral High-Performance Liquid Chromatography

Enantioseparation Of Etodolac And Its Intermediate On Chiral Stationary Phase By High Pherformance Liquid Chromatography

Establishment of Reverse-Phase High-Performance Liquid Chromatography with Chiral Reagent Derivatization for Separation of Fexofenadine Enantiomers

Direct Separation of Pregabalin Enantiomers Using a Zwitterionic Chiral Selector by High Performance Liquid Chromatography Coupled to Mass Spectrometry and Ultraviolet Detection

Simultaneous Determination of Aspirin,Ethenzamide,Caffeine in AEC Tablet by HPLC

Enantiomeric Separation of Meclizine Hydrochloride in Pharmaceutical Dosage Form by HPLC Method

Separation and determination of norepinephrine, epinephrine and isoprinaline enantiomers by capillary electrophoresis in pharmaceutical formulation and human serum.

Development and validation of a capillary electrophoresis method for the determination of escitalopram and sensitive quantification of its enantiomeric impurity in formulations

A Novel Two-Step Liquid-Liquid Extraction Procedure Combined with Stationary Phase Immobilized Human Serum Albumin for the Chiral Separation of Cetirizine Enantiomers along with M and P Parabens

Chiral Separation and Determination of Etoxazole Enantiomers in Vegetables by Normal-Phase and Reverse-Phase High Performance Liquid Chromatography

Characterization of Elvitegravir and Its Related Impurities Using ESI–LC–MS, NMR Techniques, Method Development and Validation of Its Related Substances by HPLC Method